CHIMERIX INC. - COMMON STOCK

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

07 Feb 2025 12:39:59 By NetDania Notify

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

30 Jan 2025 12:14:05 By NetDania Notify

Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium

29 Jan 2025 16:15:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

27 Jan 2025 10:00:53 By NetDania Notify

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

24 Jan 2025 16:01:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

21 Jan 2025 11:17:28 By NetDania Notify

Chimerix to Speak Today at The White House Cancer Moonshot Forum

13 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

06 Jan 2025 09:45:09 By NetDania Notify

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

02 Jan 2025 10:02:00 By NetDania Notify

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

30 Dec 2024 09:45:07 By NetDania Notify

Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma

30 Dec 2024 07:00:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

27 Dec 2024 09:53:06 By NetDania Notify

NetDania - New 12 months High: CHIMERIX INC. - COMMON STOCK

10 Dec 2024 09:48:14 By NetDania Notify

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

09 Dec 2024 16:01:00 By Nasdaq GlobeNewswire

Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

06 Dec 2024 16:01:00 By Nasdaq GlobeNewswire

Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting

11 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update

07 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024

01 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 Oct 2024 16:31:09 By Nasdaq GlobeNewswire

Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference

03 Sep 2024 07:00:00 By Nasdaq GlobeNewswire